Evidence map›Paper›PMID 40835412›Full record

ArticleArchives of disease in childhood2025

Inhaled salbutamol delivery in small children with disposable and reusable spacers: an in vitro study.

Laura Ojanperä, Lauri Lehtimäki, Balázs Kelemen, Peter Csonka

Abstract read
In one paragraph

Article in Archives of disease in childhood, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laura OjanperäTampere Universities, Tampere, Pirkanmaa, Finland.ORCID 0009-0002-6429-7045
Lauri LehtimäkiTampere Universities, Tampere, Pirkanmaa, Finland.ORCID 0000-0003-1586-4998
Balázs KelemenTampere Universities, Tampere, Pirkanmaa, Finland.
Peter CsonkaTampere Universities, Tampere, Pirkanmaa, Finland peter.csonka@tuni.fi.ORCID 0000-0003-0819-7875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResearch on spacers for paediatric breathing patterns is limited, especially for disposable types, which may be a practical alternative to reusable valved holding chambers (VHC) in certain clinical settings.

methodsIn vitro, the fine particle dose (FPD) of salbutamol from a pressurised metered-dose inhaler (pMDI) was tested using two paperboard spacers-DispozABLE (Diz) and LiteAire (LA)-and three reusable VHCs: AeroChamber Plus Flow-Vu (AC), EasyChamber (EC) and OptiChamber Diamond (OC). The pMDI+VHC setup was connected to a child throat model without a facemask. Salbutamol availability for inhalation was measured using a Next Generation Impactor under three paediatric breathing patterns: calm breathing (6 and 4 year olds) and obstructive breathing.

resultsMedian FPD in the respirable range (1-5 µm) was significantly higher for EC compared with LA, Diz and AC. Obstructive breathing increased throat deposition for all spacers, with Diz showing the highest. LA had the lowest throat deposition in calm breathing, and EC in obstructive breathing.

conclusionTraditional VHCs, especially EC and OC, outperformed disposable spacers. Among disposables, the valved LA performed better than the valveless Diz and may offer a cost-effective, practical alternative to reusable spacers in specific scenarios.

Indexed as

AlbuterolBronchodilator AgentsInhalation SpacersMetered Dose InhalersAdministration, InhalationChildChild, PreschoolDisposable EquipmentEquipment DesignEquipment ReuseHumansParticle SizeAlbuterolBronchodilator AgentsPaediatric Emergency MedicinePaediatricsPharmacologyRespiratory Medicine

Identifiers

PMID40835412
PMCPMC12772549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.